MedPlus Health Services Limited MEDPLUS.NS · Stock Open MedPlus Health Services Limited in new tab
Analyst price targets
Recent rating changes, newest first
MedPlus Health Services Limited Analysis (MEDPLUS.NS)
Is MedPlus Health Services Limited a good investment? MedPlus Health Services Limited (MEDPLUS.NS) is currently trading at 594.70 INR. Market analysts have a consensus price target of 993.14 INR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 34.93. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: MedPlus Health Services Limited is expected to release its next earnings report on Oct. 27, 2026. The market consensus estimate for Forward EPS is 22.68.
Investor FAQ
Does MedPlus Health Services Limited pay a dividend?
No, it does not currently pay a dividend.
What asset class is MedPlus Health Services Limited?
MedPlus Health Services Limited is classified as a Stock.
When is the next earnings date?
The next earnings date is projected to be Oct. 27, 2026. The company currently has a trailing EPS of 17.52.
Company Profile
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness items, such as prescription medicines, over-the-counter drugs, vitamins, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soaps, detergents, and sanitizers. The company also engages in wholesale cash and carry; provision of diagnostic, pathological, and laboratory testing services, as well as contract manufacturing of private-label pharmaceuticals, wellness products, and FMCG goods; and operates diagnostic centres. It distributes its products through retail and online channels. The company was incorporated in 2006 and is based in Hyderabad, India.
Community Discussion